Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral vs intramuscular vitamin K1 for prevention of vitamin K deficiency bleeding in preterm infants
ChiCTR2500111395Phase 4Not yet recruiting
- Sponsor
- Nanjing Maternal and Child Health Hospital
- Start
- Oct 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of phytomenadione in vitamin K deficiency bleeding (VKDB) (4 arms), sponsored by Nanjing Maternal and Child Health Hospital. Primary endpoint: Plasma PIVKA-II level at 12 weeks postnatal age. Planned start Oct 2025; status: not yet recruiting.
02
Drugs
phytomenadione
03
Conditions
vitamin K deficiency bleeding (VKDB)
Beyond the preview
Go deeper on ChiCTR2500111395.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500111395.